1. Akil H, Watson SJ, Young E, Lewis ME, Khachaturian H, Walker JM. Endogenous opioids: biology and function. Annu Rev Neurosci 1984;7:223–255.

2. Alzheimer C, ten Bruggencate G. Nonopioid actions of the kappa-opioid receptor agonists, U 50488H and U69593, on electrophysiologic properties of hippocampal CA3 neurons in vitro. J Pharmacol Exp Ther 1990;255:900–905.

3. Barg J, Belcheva MM, Rowinski J, Coscia CJ. Kappa-opioid agonist modulation of [3H]thymidine incorporation into DNA: evidence for the involvement of pertussis toxin-sensitive G-protein-coupled phosphoinositide turnover. J Neurochem 1993;60:1505–1511.

4. Bean BP. Neurotransmitter inhibition of neuronal calcium currents by changes in Ca channel voltage dependence. Nature 1989; 340:153–156.

5. Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993;361:31–39.

6. Bradler JE, Barrioneuvo G. Heterosynaptic correlates of long-term potentiation induction in hippocampal CA3 neurons. Neuroscience 1990;35:265–271.

7. Bramham CR. Opioid receptor dependent long-term potentiation: peptidergic regulation of synaptic plasticity in the hippocampus. Neurochem Int 1992;20:441–455.

8. Bramham CR, Errington ML, Bliss TVP. Naloxone blocks the induction of long-term potentiation in the lateral but not in the medial perforant pathway in the anesthetized rat. Brain Res 1988;449:352–356.

9. Bramham CR, Milgram NW, Srebro B. Delta opioid receptor activation is required to induce LTP of synaptic transmission in the lateral perforant path in vivo. Brain Res 1991;567:42–50.

10. Caudle RM, Chavkin C. Mu opioid receptor activation reduces inhibitory postsynaptic potentials in hippocampal CA3 pyramidal cells of rat and guinea pig. J Pharmacol Exp Ther 1990;252:1361–1369.

11. Caudle RM, Wagner JJ, Chavkin C. Endogenous opioids released from perforant path modulate norepinephrine actions and inhibitory postsynaptic potentials in guinea pig CA3 pyramidal cells. J Pharmacol Exp Ther 1991;258:18–26.

12. Chavkin C. In: Pasternak GW, ed. The opiate receptors. Clifton, NJ: Humana Press, 1988;273–303.

13. Chavkin C, Bakhit C, Weber E, Bloom F. Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampus. Proc Natl Acad Sci USA 1983;80:7669–7673.

14. Chavkin C, Shoemaker W, McGinty J, Bloom FE. Characterization of the prodynorphin and proenkephalin neuropeptide systems in rat hippocampus. J Neurosci 1985;5:808–816.

15. Chavkin C, Bloom FE. Opiate antagonists do not alter neuronal responses to stimulation of opioid-containing pathways in rat hippocampus. Neuropeptides 1985;7:19–22.

16. Chavkin C, Neumaier JF, Swearengen E. Opioid receptor mechanisms in the rat hippocampus. In: McGinty J, Friedman D, eds. NIDA research monograph, vol. 82. Washington, DC: US Government Printing Office 1988;94–117.

17. Chen L, Huang L-YM. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron 1991;7:319–326.

18. Chen Y, Mestek A, Liu J, Hurley JA, Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol 1993;44:8–12.

19. Childers SR. Opioid receptor-coupled second messenger systems. Life Sci 1991;48:1991–2003.

20. Christie MJ, North RA. Agonists at mu-opioid, M2-muscarinic and GABA receptors increase the same potassium conductance in rat lateral parabrachial neurones. Br J Pharmacol 1988;5:896–902.

21. Claiborne BJ, Xiang Z, Brown TH. Hippocampal circuitry complicates analysis of long-term potentation in mossy fiber synapses. Hippocampus 1993;115–122.

22. Cohen GA, Doze VA, Madison DV. Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron 1992;9:325–335.

23. Collier TJ, Routtenberg A. Selective impairment of declarative memory following stimulation of dentate gyrus granule cells: a naloxone-sensitive effect. Brain Res 1984;310:384–387.

24. Collier TJ, Quirk GJ, Routenberg A. Separable roles of hippocampal granule cells in forgetting and pyramidal cells in remembering spatial information. Brain Res. 1987;409:316–328.

25. Crain SM, Shen K-F. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol 1990;11:77–81.

26. Cruciani RA, Dvorkin B, Morris SA, Crain SM, Makman MH. Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. Proc Natl Acad Sci USA 1993;90:3019–3023.

27. Decker MW, Introini-Collison IB, McGaugh JL. Effects of naloxone on Morris water maze learning in the rat: enhanced acquisition with pretraining but not posttraining administration. Psychobiology 1989;17:270–275.

28. Derrick BE, Weinberger SB, Martinez JL. Opioid receptors are involved in an NMDA receptor-independent mechanism of LTP induction at hippocampal mossy fiber–CA3 synapses. Brain Res Bull 1991;27:219–223.

29. Derrick BE, Rodriguez SB, Lieberman DN, Martinez JL. Mu opioid receptors are associated with the induction of hippocampal mossy fiber long-term potentiation. J Pharmacol Exp Ther 1992;263:725–733.

30. Duggan AW, North RA. Electrophysiology of opioids. Pharmacol Rev 1984;35:219–281.

31. Evans CJ, Keith DE, Morrison H, Magendzo K, Edwards RH. Cloning of a delta opioid receptor by functional expression. Science 1992;258:1952–1955.

32. Gall C, Brecha N, Karten HJ, Chang K-J. Localization of enkephalin-like immunoreactivity to identified axonal and neuronal populations of the rat hippocampus. J Comp Neurol 1981; 198:335–350.

33. Gallagher M, King RA, Young NB. Opiate antagonists improve spatial memory. Science 1983;221:975–976.

34. Gallagher M, Bostock E, King RA. Effects of opiate antagonists on spatial memory in young and aged rats. Behav Neural Biol 1985;44:374.

35. Gannon RL, Terrian DM. U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals. Brain Res 1991;548:242–247.

36. Gintzler AR, Xu H. Different G proteins mediate the opioid inhibition or enhancement of evoked [5-methionine]enkephalin release. Proc Natl Acad Sci USA 1991;88:4741–4745.

37. Hanse E, Gustafsson B. Long-term potentiation and field EPSPs in the lateral and medial perforant paths in the dentate gyrus in vitro: a comparison. Eur J Neurosci 1992;4:1191–1201.

38. Harris HW, Nestler EJ. Opiate regulation of signal transduction pathways. In: Hammer RP, ed. The neurobiology of opiates. England: CRC P, 1993;301–331.

39. Hong JS, McGinty JF, Lee PHK, Xie CW, Mitchell CL. Relationship between hippocampal opioid peptides and seizures. Prog Neurobiol 1993;40:507–528.

40. Houser CR, Miyashiro JE, Walsh GO, Rich JR, Delgado-Escueta AV. Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J Neurosci 1990;10:267–282.

41. Ishihara K, Katsuki H, Sugimura M, Kaneko S, Satoh M. Different drug-susceptibilities of long-term potentiation in three input systems to the CA3 region of the guinea pig hippocampus in vitro. Neuropharmacology 1990;29:487–492.

42. Iwama T, Ishihara K, Takagi H, Satoh M. Possible mechanism involved in the inhibitory action of U-50, 488H, an opioid kappa agonist, on guinea pig hippocampal CA3 pyramidal neurons in vitro. J Pharmacobiodyn 1987;10:564–570.

43. Jackisch R, Geppert M, Brenner AS, Illes P. Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit. Naunyn Schmiedebergs Arch Pharmacol 1986;332: 156–162.

44. Jackisch R, Geppert M, Illes P. Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit. J Neurochem 1986;46:1802–1810.

45. Jan LY, Jan YN. Peptidergic transmission in sympathetic ganglia of the frog. J Physiol (Lond) 1982;327:219–246.

46. Jiang H-K, Owyang V, Hong J-S, Gallagher M. Elevated dynorphin in the hippocampal formation of aged rats: relation to cognitive impairment on a spatial learning task. Proc Natl Acad Sci USA 1989;86:2948–2951.

47. Johnston D, Williams S, Jaffe D, Gray R. NMDA-receptor-independent long-term potentiation. Annu Rev Physiol 1992;54:489–505.

48. Kangraga I, Randic M. Outflow of endogenous aspartate and glutamate from the rat spinal dorsal horn in vivo by activation of low- and high-threshold primary afferent fibers. Modulation by mu-opioids. Brain Res 1991;553:347–352.

49. Khachaturian H, Lewis ME, Schafer MK-H, Watson SJ. Anatomy of the CNS opioid systems. Trends Neurosci 1985;8:111–119.

50. Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 1992;9:12048–12052.

51. Lambert NA, Harrison NL, Teyler TJ. Evidence for mu opiate receptors on inhibitory terminals in area CA1 of rat hippocampus. Neurosci Lett 1991;124:101–104.

52. Linseman MA, Corrigall WA. Effects of morphine on CA1 versus dentate hippocampal field potentials following systemic administration in freely moving rats. Neuropharmacology 1981;21:361–366.

53. Loh HH, Smith AP. Molecular characterization of opioid receptors. Annu Rev Pharmacol Toxicol 1990;30:123–147.

54. Lundberg JM, Rudehill A, Sollevi A, Theodorsson-Norheim E, Hamberger B. Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide V from pig spleen. Neurosci Lett 1986;63:96–100.

55. Madison DV, Nicoll RA. Enkephalin hyperpolarizes interneurones in the rat hippocampus. J Physiol (Lond) 1988;398:123–130.

56. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ. Anatomy of CNS opioid receptors. Trends Neurosci 1988;11:308–314.

57. Martin MR. Naloxone and long-term potentiation of hippocampal CA3 field potentials in vitro. Neuropeptides 1983;4:45–50.

58. Martinez JL, Janak PH, Weinberger SB, Schulties G, Derrick BE. In: Erinoff L, ed. NIDA research monograph, vol 97. Washington, DC: US Government Printing Office, 1990;48–78.

59. McFadzean I. The ionic mechanisms underlying opioid actions. Neuropeptides 1988;11:173–180.

60. McFadzean I, Lacey MG, Hill RG, Henderson G. Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro. Neuroscience 1987;20:231–239.

61. McGaugh JL. Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annu Rev Neurosci 1989;12:255–287.

62. McGinty J, Henricksen S, Goldstein A, Terenius L, Bloom FE. Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity. Proc Natl Acad Sci USA 1983; 80:589–593.

63. McLean S, Rothman R, Jacobson A, Rice K, Herkenham M. J Comp Neurol 1987;255:497–510.

64. Misawa H, Ueda H, Satoh M. Kappa-opioid agonist inhibits phospholipase C, possibly via an inhibition of G-protein activity. Neurosci Lett 1990;112:324–327.

65. Miyake M, Christie MJ, North RA. Single potassium channels opened by opioids in rat locus ceruleus neurons. Proc Natl Acad Sci USA 1989;86:3419–3422.

66. Moises HC, Walker JM. Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat. Eur J Pharmacol 1985;108:85–98.

67. Moore SD, Madamba SG, Schweitzer P, Siggins GR, Voltage dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro. J Neurosci 1994;14(2):809–820.

68. Morris RGM, Garrud P, Rawlins JNP, O'Keefe J. Place navigation is impaired in rats with hippocampal lesions. Nature 1982;297: 681–683.

69. Mulder AH, Schoffelmeer ANM. Multiple opioid receptors and presynaptic modulation of neurotransmitter release in the brain. Handbook Exp Pharmacol 1993;104:125–144.

70. Neumaier JF, Chavkin C. Release of endogenous opioid peptides displaces [3H]diprenorphine binding in rat hippocampal slices. Brain Res 1989;493:292–302.

71. Nicoll RA, Siggins GR, Ling N, Bloom FE, Guillemin, R. Neuronal actions of endorphins and enkephalins among brain regions: a comparative microiontophoretic study. Proc Natl Acad Sci USA 1977;74:2584–2588.

72. Nicoll RA, Alger BE, Jahr CE. Enkephalin blocks inhibitory pathways in the vertebrate CNS. Nature 1980;287:22–25.

73. North RA. Opioid actions on membrane ion channels. Handbook Exp Pharmacol 1993;104:773–797.

74. Olton DS, Becker JT, Handelmann GE. Hippocampus, space and memory. Behav Brain Sci 1979;2:313–365.

75. Pasternak GW. Opioid receptors. In: Meltzer HY, ed. Psycopharmacology: the third generation of progress. New York: Raven Press, 1987;281–288.

76. Periyasamy S, Hoss W. Kappa opioid receptors stimulate phosphoinositide turnover in rat brain. Life Sci 1990;47:219–225.

77. Pinnock RD. A highly selective kappa-opioid receptor agonist, CI-977, reduces excitatory synaptic potentials in the rat locus coeruleus in vitro. Neuroscience 1992;47:87–94.

78. Pollard H, Bouthenet ML, Moreau J, Souil E, Verroust P, Ronco P, Schwartz, JC. Detailed immunoautoradiographic mapping of enkephalinase (EC 3.4.24.11) in rat central nervous system: comparison with enkephalins and substance P. Neuroscience 1989;30:339–376.

79. Rekling JC. Effects of met-enkephalin on GABAergic spontaneous miniature IPSPs in organotypic slice cultures of the rat hippocampus. J Neurosci 1993;13:1954–1964.

80. Ruskin KI, Randic M. Modulation of NMDA-induced currents by mu-opioid receptor agonist DAGO in acutely isolated rat spinal dorsal horn neurons. Neurosci Lett 1991;124:208–212.

81. Satoh M, Ishihara K, Katsuki H, Sugimura M. Adv Biosci 1989;75:193–196.

82. Schroeder JE, Fischbach PS, Zheng D, McClesky EW. Activation of mu opioid receptors inhibits transient high- and low-threshold Ca2+ currents, but spares a sustained current. Neuron 1991;6:13–20.

83. Shen KZ, North RA, Surprenant A. Potassium channels opened by noradrenaline and other transmitters in excised membrane patches of guinea-pig submucosal neurones. J Physiol (Lond) 1992;445:581–599.

84. Siggins GR. Zieglgansberger W. Morphine and opioid peptides reduce inhibitory synaptic potentials in hippocampal pyramidal cells in vitro without alteration of membrane potential. Proc Natl Acad Sci USA 1981;78:5235–5239.

85. Simmons ML, Wagner JJ, Caudle RM, Chavkin C. Endogenous opioid regulation of norepinephrine release in guinea pig hippocampus. Neurosci Lett 1992;141:84–88.

86. Simon EJ. Opioid receptors and endogenous opioid peptides. Med Res Rev 1991;11:357–374.

87. Sloviter RS. Possible functional consequences of synaptic reorganization in the dentate gyrus of kainate-treated rats. Neurosci Lett 1992;137:91–96.

88. Terman GW, Wagner JJ, Chavkin C. Endogenous dynorphin blocks induction of LTP in the guinea pig hippocampal dentate gyrus. Soc Neurosci Abstr 1993;19:1158.

89. Tortella FC. Endogenous opioid peptides and epilepsy: quieting the seizing brain? Trends Pharmacol 1988;9:366–372.

90. Tsunoo A, Yoshii M, Narahashi T. Block of calcium channels by enkephalin and somatostatin in neuroblastoma–glioma hybrid NG108-15 cells. Proc Natl Acad Sci USA 1986;83:9832–9836.

91. Ueda H, Nozaki M, Satoh M. Multiple opioid receptors and GTP-binding proteins. Comp Biochem Physiol C 1991;98:157–169.

92. Wagner JJ, Caudle RM, Neumaier JF, Chavkin C. Stimulation of endogenous opioid release displaces mu receptor binding in rat hippocampus. Neuroscience 1990;37:45–53.

93. Wagner JJ, Evans CJ, Chavkin C. Focal stimulation of the mossy fibers releases endogenous dynorphins that bind k1-opioid receptors in guinea pig hippocampus. J Neurochem 1991;57:333–343.

94. Wagner JJ, Caudle RM, Chavkin C. Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus. J Neurosci 1992;12:132–141.

95. Wagner JJ, Terman GW, Chavkin C. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature 1993;363:451–454.

96. Walker J, Moises H, Coy D, Baldrighi G, Akil H. Nonopiate effects of dynorphin and des-tyr-dynorphin. Science 1982;218: 1136–1138.

97. Weisskopf MG, Zalutsky RA, Nicoll RA. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 1993;362:423–427.

98. Werling LL, Brown SR, Cox BM. Opioid receptor regulation of the release of norepinephrine in brain. Neuropharmacology 1987;26:987–996.

99. Wigstrom H, Gustafsson B. Facilitated induction of hippocampal long-lasting potentiation during blockade of inhibition. Nature 1983;301:603–604.

100. Williams JT, North RA, Tokimasa T. Inward rectification of resting and opiate-activated potassium currents in rat locus coeruleus neurons. J Neurosci 1988;8:4299–4306.

101. Wimpey TL, Chavkin C. Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation. Neuron 1991;6:281–289.

102. Wimpey TL, Chavkin C. 8-Bromo-cAMP blocks opioid activation of a voltage-gated potassium current in isolated hippocampal neurons. Neurosci Lett 1992;137:137–140.

103. Xie C-W, Lewis DV. Opioid-mediated facilitation of long-term potentiation at the lateral perforant path-dentate granule cell synapse. J Pharmacol Exp Ther 1991;256:289–296.

104. Xie C-W, Morrisett RA, Lewis DV. Mu opioid receptor-mediated modulation of synaptic currents in dentate granule cells of rat hippocampus. J Neurophysiol 1992;68:1113–1120.

105. Yasuda K, Raynor K, Kong H, Breder CD, Takeda J, Reisine T, Bell GI. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc Natl Acad Sci USA 1993;90:6736–6740.

106. Zalutsky RA, Nicoll RA. Comparison of two forms of long-term potentiation in single hippocampal neurons. Science 1990;248: 1619–1624.

107. Zieglgansberger W, French ED, Siggins GR, Bloom FE. Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science 1979;205:415–417.

Back to Chapter